Report for Yoon KH

General

Full name :

First name :

Mail :

Zip Code :

City :

Country :

Email :

Phone :

Fax :

Website :

Directory :

References (6)

Title : The impact of depression on language function in individuals with Alzheimer's disease: a pre\/post-treatment design - Yoon_2023_Ann.Gen.Psychiatry_22_4
Author(s) : Yoon KH , Moon YS , Kim DH
Ref : Ann Gen Psychiatry , 22 :4 , 2023
Abstract : Yoon_2023_Ann.Gen.Psychiatry_22_4
ESTHER : Yoon_2023_Ann.Gen.Psychiatry_22_4
PubMedSearch : Yoon_2023_Ann.Gen.Psychiatry_22_4
PubMedID: 36737766

Title : Efficacy and safety of evogliptin monotherapy in patients with type 2 diabetes and moderately elevated glycated haemoglobin levels after diet and exercise - Park_2017_Diabetes.Obes.Metab_19_1681
Author(s) : Park J , Park SW , Yoon KH , Kim SR , Ahn KJ , Lee JH , Mok JO , Chung CH , Han KA , Koh GP , Kang JG , Lee CB , Kim SH , Kwon NY , Kim DM
Ref : Diabetes Obes Metab , 19 :1681 , 2017
Abstract : Park_2017_Diabetes.Obes.Metab_19_1681
ESTHER : Park_2017_Diabetes.Obes.Metab_19_1681
PubMedSearch : Park_2017_Diabetes.Obes.Metab_19_1681
PubMedID: 28448688

Title : Efficacy and safety of adding evogliptin versus sitagliptin for metformin-treated patients with type 2 diabetes: A 24-week randomized, controlled trial with open label extension - Hong_2017_Diabetes.Obes.Metab_19_654
Author(s) : Hong SM , Park CY , Hwang DM , Han KA , Lee CB , Chung CH , Yoon KH , Mok JO , Park KS , Park SW
Ref : Diabetes Obes Metab , 19 :654 , 2017
Abstract : Hong_2017_Diabetes.Obes.Metab_19_654
ESTHER : Hong_2017_Diabetes.Obes.Metab_19_654
PubMedSearch : Hong_2017_Diabetes.Obes.Metab_19_654
PubMedID: 28058750

Title : Anagliptin and sitagliptin as add-ons to metformin for patients with type 2 diabetes: a 24-week, multicentre, randomized, double-blind, active-controlled, phase III clinical trial with a 28-week extension - Jin_2015_Diabetes.Obes.Metab_17_511
Author(s) : Jin SM , Park SW , Yoon KH , Min KW , Song KH , Park KS , Park JY , Park IB , Chung CH , Baik SH , Choi SH , Lee HW , Lee IK , Kim DM , Lee MK
Ref : Diabetes Obes Metab , 17 :511 , 2015
Abstract : Jin_2015_Diabetes.Obes.Metab_17_511
ESTHER : Jin_2015_Diabetes.Obes.Metab_17_511
PubMedSearch : Jin_2015_Diabetes.Obes.Metab_17_511
PubMedID: 25523633

Title : A randomized, placebo-controlled, double-blind, phase 3 trial to evaluate the efficacy and safety of anagliptin in drug-naive patients with type 2 diabetes - Yang_2015_Endocr.J_62_449
Author(s) : Yang HK , Min KW , Park SW , Chung CH , Park KS , Choi SH , Song KH , Kim DM , Lee MK , Sung YA , Baik SH , Kim IJ , Cha BS , Park JH , Ahn YB , Lee IK , Yoo SJ , Kim J , Park Ie B , Park TS , Yoon KH
Ref : Endocrine Journal , 62 :449 , 2015
Abstract : Yang_2015_Endocr.J_62_449
ESTHER : Yang_2015_Endocr.J_62_449
PubMedSearch : Yang_2015_Endocr.J_62_449
PubMedID: 25819061

Title : Effect of initial combination therapy with sitagliptin, a dipeptidyl peptidase-4 inhibitor, and pioglitazone on glycemic control and measures of beta-cell function in patients with type 2 diabetes - Yoon_2011_Int.J.Clin.Pract_65_154
Author(s) : Yoon KH , Shockey GR , Teng R , Golm GT , Thakkar PR , Meehan AG , Williams-Herman DE , Kaufman KD , Amatruda JM , Steinberg H
Ref : Int J Clin Pract , 65 :154 , 2011
Abstract : Yoon_2011_Int.J.Clin.Pract_65_154
ESTHER : Yoon_2011_Int.J.Clin.Pract_65_154
PubMedSearch : Yoon_2011_Int.J.Clin.Pract_65_154
PubMedID: 21235696